Our core services

PRMA Consulting are experts in pricing, reimbursement, and market access. We work in close partnership with our clients to deliver integrated and innovative solutions to market access.

Market access

Development of value strategy based on in-depth understanding of HTA/P&R evidence and methodological requirements, with critical insight from payors and clinicians

Learn more

Pricing & reimbursement

Primary and secondary research to understand the current and likely future landscape and inform the value proposition and P&R strategy

Learn more

Economic models & evidence synthesis

Development of methodologically robust economic models and evidence synthesis according to HTA agency requirements

Learn more

Patient-reported outcomes

Strategies to optimize the generation of patient-centered outcomes data to support the value proposition to regulators, reimbursement agencies, and patients

Learn more

Real-world evidence

Quantitative research into treatment, disease burden, and resource use to inform multiple elements of the market access strategy

Learn more

Personalized medicine

In-depth understanding of the complexities and challenges around market access for companion diagnostic–drug pairings

Learn more

PRMA HealthCheck™

An interactive strategic planning tool designed to evaluate the planned and required evidence for your product on a country-by-country basis.

Learn more

PRMA webinars

We regularly hold webinars on thought-leading issues of critical importance in market access. These webinars are available to watch online.

Learn more

Forthcoming events

Our hematology experts will be at ASH annual meeting from 5 Dec–8 Dec

Meet with us »

Our experts will be at ISPOR 21st annual international meeting from 21–25 May

Meet with us »

Our oncology experts will be at ASCO annual meeting from 3–7 June

Meet with us »

Our hematology experts will be at EHA 21st congress 9–12 June

Meet with us »

Syndicated reports

PRMA Insights: Pricing and Reimbursement Success are key resources for planning your market access strategy

AMNOG syndicated report


PRMA Insights Focus: The Impact of AMNOG on Pricing & Reimbursement in Germany and Beyond

Learn more >>

Companion diagnostics in oncology syndicated report

Companion diagnostics

PRMA Insights: Market Access Success for Companion Diagnostic–Drug Pairings in Oncology

Learn more >>

NSCLC syndicated report


PRMA Insights: Pricing & Reimbursement Success in NSCLC

Learn more >>

Metastatic breast cancer syndicated report

Metastatic breast cancer

PRMA Insights: Pricing & Reimbursement Success in Metastatic Breast Cancer

Learn more >>

Renal cell carcinoma syndicated report

Renal cell carcinoma

PRMA Insights: Pricing & Reimbursement Success in Renal Cell Carcinoma

Learn more >>

Rheumatoid arthritis syndicated report

Rheumatoid arthritis

PRMA Insights: Pricing & Reimbursement Success in Rheumatoid Arthritis

Learn more >>

Psoriasis syndicated report


PRMA Insights: Pricing & Reimbursement Success in Psoriasis

Learn more >>

COPD syndicated report


PRMA Insights: Pricing & Reimbursement Success in COPD

Learn more >>

"PRMA Consulting is the best consultancy we've worked with in every way – flexibility, responsiveness, adherence to timelines and quality of the work."
Head of Market Access, Health Economics, and Pricing – top-30 global pharmaceutical company